Expensive drugs on GP blacklist
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Expensive drugs are being blacklisted by health trusts in an effort to save money, the GPs' newspaper Pulse has reported. It found that of 134 primary care organisations, half had lists of drugs that GPs are banned from prescribing, and 73 had added to the list in the past year or brought in additional restrictions on prescribing.
Banned treatments include medication approved by the National Institute for Health and Clinical Excellence such as gliptins for diabetes and denosumab for osteoporosis. Other medication for Parkinson's and some contraceptive pills have also been banned, along with the weight-loss drug orlistat.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments